Application of activity-based probes to the study of enzymes involved in cancer progression.

Many tumor cells have elevated levels of hydrolytic and proteolytic enzymes, presumably to aid in key processes such as angiogenesis, cancer cell invasion, and metastasis. Functional roles of enzymes in cancer progression are difficult to study using traditional genomic and proteomic methods because the activities of these enzymes are often regulated by post-translational mechanisms. Thus, methods that allow for the direct monitoring of enzyme activity in a physiologically relevant environment are required to better understand the roles of specific players in the complex process of tumorigenesis. This review highlights advances in the field of activity-based proteomics, which uses small molecules known as activity-based probes (ABPs) that covalently bind to the catalytic site of target enzymes. We discuss the application of ABPs to cancer biology, especially to the discovery of tumor biomarkers, the screening of enzyme inhibitors, and the imaging of enzymes implicated in cancer.

[1]  H. Ploegh,et al.  Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Ralph Weissleder,et al.  Near-infrared optical imaging of proteases in cancer. , 2003, Molecular cancer therapeutics.

[3]  Kinneret Keren,et al.  Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.

[4]  Bonnie F. Sloane,et al.  Functional imaging of tumor proteolysis. , 2006, Annual review of pharmacology and toxicology.

[5]  D. Filippov,et al.  A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. , 2006, Chemistry & biology.

[6]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[7]  A. Saghatelian,et al.  An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. , 2006, Chemistry & biology.

[8]  M. Bogyo,et al.  Tagging and detection strategies for activity-based proteomics. , 2007, Current opinion in chemical biology.

[9]  M. Bogyo,et al.  Enzyme activity--it's all about image. , 2004, Trends in cell biology.

[10]  O. Vasiljeva,et al.  Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. , 2006, Cancer research.

[11]  Anna E Speers,et al.  Profiling enzyme activities in vivo using click chemistry methods. , 2004, Chemistry & biology.

[12]  G. Winberg,et al.  Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines , 2006, Molecular carcinogenesis.

[13]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[14]  Nasreen S Jessani,et al.  Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Gavin MacBeath,et al.  Protein microarrays and proteomics , 2002, Nature Genetics.

[16]  Nasreen S Jessani,et al.  Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.

[18]  Georges von Degenfeld,et al.  Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.

[19]  A. Saghatelian,et al.  Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling , 2005, Nature Biotechnology.

[20]  M. Bogyo,et al.  Proteomics meets microbiology: technical advances in the global mapping of protein expression and function , 2005, Cellular microbiology.

[21]  Dale L Boger,et al.  Discovering potent and selective reversible inhibitors of enzymes in complex proteomes , 2003, Nature Biotechnology.

[22]  M. Bogyo,et al.  Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. , 2006, Molecular cell.

[23]  D. Ferris,et al.  Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase. , 2005, Chemistry & biology.

[24]  R. Fridman,et al.  Extracellular proteases as targets for treatment of cancer metastases. , 2004, Chemical Society reviews.

[25]  B. Cravatt,et al.  Activity-based probes for proteomic profiling of histone deacetylase complexes , 2007, Proceedings of the National Academy of Sciences.

[26]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[27]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[28]  K. Anderson,et al.  Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib , 2005, Nature Methods.

[29]  Sherry L. Niessen,et al.  Activity-based Protein Profiling Implicates Urokinase Activation as a Key Step in Human Fibrosarcoma Intravasation* , 2006, Journal of Biological Chemistry.

[30]  E. Diamandis,et al.  The emerging roles of human tissue kallikreins in cancer , 2004, Nature Reviews Cancer.

[31]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[32]  A. Hermetter,et al.  Activity-based proteomics: enzymatic activity profiling in complex proteomes , 2006, Amino Acids.

[33]  Matthew Bogyo,et al.  Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening. , 2007, Current pharmaceutical design.

[34]  H. Ovaa Active-site directed probes to report enzymatic action in the ubiquitin proteasome system , 2007, Nature Reviews Cancer.

[35]  John R Yates,et al.  Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Cravatt,et al.  Trifunctional Chemical Probes for the Consolidated Detection and Identification of Enzyme Activities from Complex Proteomes*S , 2002, Molecular & Cellular Proteomics.

[37]  B. Cravatt,et al.  Mechanism-based profiling of enzyme families. , 2006, Chemical reviews.

[38]  H. Ovaa,et al.  Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells , 2007, Leukemia.

[39]  Sherry L. Niessen,et al.  Proteomic profiling of metalloprotease activities with cocktails of active-site probes , 2006, Nature chemical biology.

[40]  M. Bogyo,et al.  Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases. , 2007, Chemistry & biology.

[41]  B. Cravatt,et al.  Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype , 2002, Nature Biotechnology.

[42]  A. Burlingame,et al.  Chemical Approaches for Functionally Probing the Proteome* , 2002, Molecular & Cellular Proteomics.

[43]  Bonnie F. Sloane,et al.  Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.

[44]  K. Anderson,et al.  Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells. , 2005, Cancer research.

[45]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[46]  D. Berger,et al.  Role of Proteases in Pancreatic Carcinoma , 2005, World Journal of Surgery.

[47]  Nasreen S Jessani,et al.  A streamlined platform for high-content functional proteomics of primary human specimens , 2005, Nature Methods.